Collegium Pharmaceutical
COLL
COLL
83 hedge funds and large institutions have $235M invested in Collegium Pharmaceutical in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 36 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 88 → 83 (-5)
35% less capital invested
Capital invested by funds: $363M → $235M (-$128M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
83
Holding in Top 10
1
Calls
$526K
Puts
$267K
Top Buyers
| 1 | +$14.9M | |
| 2 | +$8.12M | |
| 3 | +$7.77M | |
| 4 |
CCM
Cadian Capital Management
New York
|
+$4.41M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$4.36M |
Top Sellers
| 1 | -$22.2M | |
| 2 | -$8.3M | |
| 3 | -$7M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$6.27M |
| 5 |
PA
Perceptive Advisors
New York
|
-$3.06M |